MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
3.630
+0.030
+0.83%
After Hours: 3.610 -0.02 -0.55% 19:30 09/11 EDT
OPEN
3.680
PREV CLOSE
3.600
HIGH
3.769
LOW
3.610
VOLUME
74.71K
TURNOVER
--
52 WEEK HIGH
14.68
52 WEEK LOW
2.600
MARKET CAP
31.58M
P/E (TTM)
-0.2118
1D
5D
1M
3M
1Y
5Y
1D
Memorial Sloan Kettering Cancer Center Joins BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer
Benzinga · 4d ago
Weekly Report: what happened at BCTX last week (0831-0904)?
Weekly Report · 5d ago
Weekly Report: what happened at BCTX last week (0824-0828)?
Weekly Report · 08/31 09:07
BriaCell Advances Off-the-Shelf Personalized Melanoma Vaccine Toward Clinic
TipRanks · 08/24 12:11
BriaCell Therapeutics Advances Bria-MEL+ Whole Cell Melanoma Immunotherapy Vaccine Candidate Toward Clinical Development With Key Genetic Engineering Milestone
Benzinga · 08/24 11:33
Weekly Report: what happened at BCTX last week (0817-0821)?
Weekly Report · 08/24 09:07
Weekly Report: what happened at BCTX last week (0810-0814)?
Weekly Report · 08/17 09:07
Weekly Report: what happened at BCTX last week (0803-0807)?
Weekly Report · 08/10 09:06
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.